CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY

CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY

Saved in:

Bibliographic Details
Main Author:	Lodovico Balducci
Format:	Article
Language:	English
Published:	PAGEPress Publications 2014-05-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/1354
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Current developments in personalized treatment strategies for elderly acute myelogenous leukemia patients
by: Xueting Hou, et al.
Published: (2025-01-01)

Acute myelogenous leukemia revealed by acute appendicitis
by: Sanae El Marzguioui, et al.
Published: (2020-01-01)

Permanent Sensorineural Deafness in a Patient with Chronic Myelogenous Leukemia Secondary to Intracranial Hemorrhage
by: Sakshi Kapur, et al.
Published: (2013-01-01)

MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
by: Ibrahim C. Haznedaroglu
Published: (2013-12-01)

IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?
by: Federica Sorà, et al.
Published: (2021-10-01)

Monitoring the response to tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML)
by: Ibrahim C. Haznedaroglu
Published: (2014-08-01)

PROGNOSTIC SIGNIFICANCE OF NRAS GENE MUTATIONS IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA
by: Rabab Aly, et al.
Published: (2011-11-01)

PROGNOSTIC SIGNIFICANCE OF NRAS GENE MUTATIONS IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA
by: Adel A. Hagag, et al.
Published: (2011-01-01)

Pulmonary Complications of Azanucleoside Therapy in Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia
by: Manuel Molina, et al.
Published: (2015-01-01)

LOW INCIDENCE OF ANTI-PF4/HEPARIN ANTIBODIES IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
by: Håkon Reikvam, et al.
Published: (2024-06-01)

Antiproliferative Effect of Spilanthes Acmella Extracts on Human Cervix Adenocarcinoma and Human Myelogenous Leukemia Cells
by: Tambur Zoran, et al.
Published: (2024-12-01)

Bacillus cereus Typhlitis in a Patient with Acute Myelogenous Leukemia: A Case Report and Review of the Literature
by: James D. Denham, et al.
Published: (2018-01-01)

Role of MicroRNAs in Chronic Myeloid Leukemia (CML) Treatment, Biomarkers, and Resistance to Tyrosine Kinase Inhibitor: A Bioinformatics-Based Analysis
by: Syarifah Faezah binti Syed Mohamad, et al.
Published: (2024-11-01)

LSP1 promotes the progression of acute myelogenous leukemia by regulating KSR/ERK signaling pathway and cell migration
by: Tan Li, et al.
Published: (2024-12-01)

Correlation analysis of bone marrow microvessel density and miRNA expression on drug resistance in patients with chronic myelogenous leukemia after tyrosine kinase inhibitor treatment
by: Yi-gang Guo, et al.
Published: (2024-12-01)

Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption
by: Judit Demeter, et al.
Published: (2021-02-01)

A challenging case of chronic myeloid leukemia (CML) with compound mutations including T315I, rapidly progressing to B-lymphoid blast crisis
by: Parichay Singh, et al.
Published: (2024-01-01)

TREATMENT OF CANCER IN THE OLDER AGED PERSON
by: Lodovico Balducci
Published: (2010-05-01)

TREATMENT OF CANCER IN THE OLDER AGED PERSON
by: Lodovico Balducci
Published: (2010-10-01)

SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection
by: Elisabetta Abruzzese, et al.
Published: (2020-04-01)

Aplasia in Chronic Phase CML Post-TKI Therapy: A Management Dilemma
by: Jeremy L. Ramdial, et al.
Published: (2019-01-01)

Dilemmas in the Diagnosis and Management of CML in Pakistan
by: Sahrish Khan, et al.
Published: (2024-12-01)

REPEATED THERAPEUTIC LEUKAPHERESIS - A SOLE TREATMENT DURING PREGNANCY AS A BRIDGE BEFORE TYROSINE KINASE INHIBITORS FOR A PREGNANT WOMAN WITH CHRONIC MYELOGENOUS LEUKEMIA – A CASE REPORT AND DISCUSSION
by: Ivan Tonev, et al.
Published: (2025-01-01)

Molecular monitoring in CML—a modern example of an old proverb
by: Jeffrey H. Lipton
Published: (2024-11-01)

DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
by: Ibrahim C. Haznedaroglu
Published: (2015-02-01)

OPTIMIZATION OF TKI SELECTION IN CML: BALANCING EFFICACY, SAFETY, AND PATIENT PREFERENCES
by: Emel İşleyen Kaya
Published: (2024-12-01)

Acute Myelogenous Leukemia with the t(7;7)(p15;p22) Translocation, a Novel Simple Variant of t(7;11)(p15;p15) Translocation: First Description
by: Motoharu Shibusawa
Published: (2021-01-01)

Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course
by: Angela McLigeyo, et al.
Published: (2020-01-01)

Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation
by: Simona Bernardi, et al.
Published: (2019-05-01)

Chronic myelogenous leukemia coexpressing V-e16a2, V-e13a2, e13a2, and e14a2 BCR::ABL1 fusion transcripts: a case report and review of the literature
by: Yang Xu, et al.
Published: (2024-12-01)

MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
by: Francesco Lococo, et al.
Published: (2013-06-01)

COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity
by: Na He, et al.
Published: (2024-11-01)

Low Renalase Levels in Newly Diagnosed CML: Dysregulation Sensitive to Modulation by Tyrosine Kinase Inhibitors
by: Jelena Milenkovic, et al.
Published: (2024-12-01)

Chronic monocytic leukemia with transformation into acute monocytic leukemia
by: I.S. Shponka, et al.
Published: (2021-03-01)

IFN‐α treatment may enable discontinuation of TKIs in NK cell‐licensed patients with CML‐CP
by: Hiroshi Ureshino, et al.
Published: (2024-12-01)

CML Developing Three Years after Therapy Completion in a Child with Ph(−) Pre-B-ALL
by: S. Hosseini, et al.
Published: (2011-01-01)

Chronic Lymphocytic Leukemia and Myelofibrosis
by: Fares Darawshy, et al.
Published: (2018-01-01)

MiCML: a causal machine learning cloud platform for the analysis of treatment effects using microbiome profiles
by: Hyunwook Koh, et al.
Published: (2025-01-01)

AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY ACUTE MYELOID LEUKEMIA
by: Gert J. Ossenkoppele, et al.
Published: (2013-02-01)

IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
by: Tomasz Sacha
Published: (2013-12-01)